- 1 What is the COVID-19 vaccine introduction toolbox?
- 2 Are there any side effects from the COVID-19 vaccine?
- 3 Is it safe to take paracetamol before receiving the COVID-19 vaccine?
- 4 What are the mild-to-moderate side effects of the COVID-19 vaccine?
- 5 Who are at higher risk of developing serious illness from COVID-19?
- 6 What is the origin of COVID-19?
- 7 When was COVID-19 first identified?
What is the COVID-19 vaccine introduction toolbox?
The COVID-19 vaccine introduction toolbox equips all countries to prepare for and implement COVID-19 vaccination by providing guidance, tools, and training. This toolbox is intended to support Ministries of Health, health workers, partner organizations, and other stakeholders.
Are there any side effects from the COVID-19 vaccine?
Like any vaccine, COVID-19 vaccines can cause mild, short term side effects, such as a low-grade fever or pain or redness at the injection site. Most reactions to vaccines are mild and go away within a few days on their own. More serious or long-lasting side effects to vaccines are possible but extremely rare.
Is it safe to take paracetamol before receiving the COVID-19 vaccine?
Taking painkillers such as paracetamol before receiving the COVID-19 vaccine to prevent side effects is not recommended. This is because it is not known how painkillers may affect how well the vaccine works.
What are the mild-to-moderate side effects of the COVID-19 vaccine?
Mild-to-moderate side effects, like a low-grade fever or muscle aches, are normal and not a cause for alarm: they are signs that the body’s immune system is responding to the vaccine, specifically the antigen (a substance that triggers an immune response), and is gearing up to fight the virus.
Who are at higher risk of developing serious illness from COVID-19?
Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.
What is the origin of COVID-19?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel severe acute respiratory syndrome coronavirus. It was first isolated from three people with pneumonia connected to the cluster of acute respiratory illness cases in Wuhan. All structural features of the novel SARS-CoV-2 virus particle occur in related coronaviruses in nature.
When was COVID-19 first identified?
On 31 December 2019, WHO was informed of cases of pneumonia of unknown cause in Wuhan City, China. A novel coronavirus was identified as the cause by Chinese authorities on 7 January 2020 and was temporarily named “2019-nCoV”.